The largest database of trusted experimental protocols

Mini 1240

Manufactured by Shimadzu
Sourced in Japan

The Mini 1240 is a compact and portable UV-Vis spectrophotometer designed for basic absorbance measurements. It features a wavelength range of 190-1100 nm and can be powered by either an AC adapter or battery. The Mini 1240 provides simple and straightforward operation for general laboratory applications.

Automatically generated - may contain errors

7 protocols using mini 1240

1

Characterization of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
All compounds’
melting points were measured using Gallan-Kamp equipment and are uncorrected.
TLC was used to assess the purity of the compounds. A Shimadzu 470
IR-spectrophotometer was used to record the infrared (IR) spectra
(KBr). 1H NMR spectra were recorded on a 500 MHz spectrometer
using CDCl3 or DMSO-d6 as a
solvent and tetramethylsilane (TMS) as an internal reference (chemical
shifts were given in ppm (δ) and coupling constants (J values) in Hertz (Hz)). The splitting patterns were designated
as singlet (s), doublet (d), doublet of doublets (dd), triplet (t),
quartet (q), or multiplet (m). The spectra of UV–vis were measured
using a Shimadzu mini1240. The fluorescence emission spectra are performed
at room temperature using a Hitachi F-7100 FL Spectrophotometer. The
Gaussian 09 program is used for quantum chemical calculations34 via the density functional theory method with
the B3LYP functional in a gaseous phase35 (link) and the 6-311++G (d,p) basis set. To conduct open circuit potential
linear and Tafel plot polarization tests in electrochemical studies,
the 352/252 model corrosion measuring technique is utilized in conjunction
with an EG&G potentiostat/galvanostat, model 273A, that operates
on IBM software. Scanning electron microscope (SEM) analysis was performed
at the unit of electronic microscopy (JEOL, JSM5400LV) at Assuit University.
+ Open protocol
+ Expand
2

Quantitative Phlorotannin Analysis in Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phlorotannin content was estimated by determining the total phenolic content (TPC) of the extracts using a modified version of the method performed by Farvin & Jacobsen [7 (link)]. The liquid extracts were diluted 10 times before analysis. To 100 μL of diluted sample 0.75 mL Folin Ciolcalteu phenol reagent (10% v/v in water) was added and mixed. After 5 min, 0.75 mL sodium-carbonate solution (7.5% Na2CO3 w/v in water) was added and mixed. The reaction was incubated for 90 minutes in room temperature in the dark. The absorbance was measured at 725 nm by a UV-vis spectrophotometer (Shimadzu UV mini−1240, Duisburg, Germany). Gallic-acid (GA, 2,3,4-trihydrobenzoic acid) was used for quantification (calibration curve: 0–250 μg mL−1). The results are expressed as grams of gallic acid equivalents (GAE) in 100 g dw (g GAE 100 g−1 dw, n = 3).
+ Open protocol
+ Expand
3

In-vitro Drug Release Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drug release experiments were carried out using a dissolution apparatus (Erweka DT 700, Germany), paddle method, rotating at 50 rpm at 37 °C in 500 ml phosphate buffer solution (pH 7.4). The sample of 5 ml which were replaced with fresh medium was taken at distinct time intervals (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 h).
In-vitro analysis of drug concentration in the samples was done by a UV spectrophotometer (Shimadzu-Mini 1240, Japan) at a wavelength of 235 nm. The release tests were performed at least for three separate experiments, the mean values of obtaining data were calculated and the cumulative percentage of drug release was plotted against time. Furthermore, in order to better characterize the drug release process, the mean dissolution time (MDT) was calculated according to the following equation:
Where i is the dissolution sample number, n is the number of dissolution sample time, t is the time at the midpoint between i and i-1, and M is the additional amount of drug dissolved between i and i-1. To assess the statistical significance between the MDTs, ANOVA with Tukey post test was carried out (17 ).
+ Open protocol
+ Expand
4

In vitro Drug Release Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro profiles of MEL and RES released from MR-SNC were studied at different pH values using a dialysis bag (Sigma Aldrich, 20 kD molecular weight cut-off) as described elsewhere37 (link)–39 (link). Briefly, 5 mL of MR-SNC was placed in a dialysis bag, followed by immersion in a fixed volume of release medium (80 mL PBS, pH 7.45, 6.5, 6, adjusted by 1N HCl). Then, the bottels were incubated in an orbital mixer (Benchmark Scientific) for 55 h at 37 ± 0.5 °C at 300 rpm. At planned time intervals (0.5, 1, 2, 4, 24, 30, 48, and 55 h), 1 mL of PBS dialysate was removed and replaced with the same volume of fresh media and then analyzed by UV–vis spectrophotometry (Mini 1240, Shimadzu Co., Japan), at two different maximum absorption wavelengths (λmax), corresponding to 297 nm for RES and 277 nm for MEL. At each pH, the amount of MEL and RES released from MR-SNC was calculated as the drug release percentage at planned time intervals relating to the quantity of the entrapped drug.
+ Open protocol
+ Expand
5

Creatinine Determination in Urine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Creatinine levels in urine samples were determined by spectrophotometry [44 (link)]. Briefly, alkaline picrate was formed by mixing picric acid (3.5 mM) and NaOH (1000 mM), and the solution was stored in darkness. Then, 1 mL of diluted urine (1/10, v/v, in ultrapure water) was mixed with 1 mL alkaline picrate, and optical density at 500 nm was measured in the spectrophotometer (Shimadzu mini 1240; Kyoto, Japan). Mycotoxin urinary concentrations were expressed as μg/g creatinine after normalization to creatinine level in the analyzed samples.
+ Open protocol
+ Expand
6

In Vitro Cisplatin Release Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro release is increasingly garnering attention as a reliable surrogate
test for assessing product performance.49 (link) The study analyzed the release of cisplatin from Cispt-SNC at pH
7.4 through in vitro testing using a dialysis bag
with a 20 kDa molecular weight cutoff from Sigma-Aldrich.50 (link) Initially, 5 mL of Cispt-SNC was placed into
the dialysis bag and immersed in a fixed volume of release medium
consisting of 80 mL of PBS with a pH of 7.4. The bottles were then
subjected to incubation for 55 h at 37 ± 0.5 °C at 300 rpm
in an orbital mixer from Benchmark Scientific. Samples were taken
at set intervals of time (0.5, 1, 2, 4, 24, 30, 48, and 65 h), where
1 mL of PBS dialysate was extracted and replaced with a fresh medium
of the same volume. The samples were analyzed using UV–vis
spectrophotometry (Mini 1240, Shimadzu Co., Japan) at a λmax
corresponding to 210 nm. In essence, the design is easy to perform,
simple, and available in all pharmaceutical laboratories under the
same setup.51 (link)
+ Open protocol
+ Expand
7

Ultracentrifugation Nanoparticle Drug Entrapment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Entrapment efficiency and drug loading were assessed by ultracentrifugation method36 (link). At first, MR-SNC solution was ultracentrifuged (Optimal L-90 k, Beckman coulter Co, USA) for 15 min at 18,200 rpm to separate the free drug from MR-SNCs. Then 1 mL of supernatant was assessed via UV–vis spectrophotometry (Mini 1240, Shimadzu Co., Japan) for evaluating of the unentrapped RES or MEL at 297 and 277 nm, respectively37 (link). Next, a standard calibration curve was prepared using various concentraions of RES and MEL (0.1–50 µg/mL for RES and 17.3–600 µg/mL for MEL, straight line with r2 = 0.98). The free drugs amounts were obtained using these curves. Finally, the entrapment efficiency (EE) and drug loading (DL) of RES and MEL on MR-SNC were calculated using the following formula: EE(%)=Total amount of drug added-Free amount of drugTotal amount of drug added×100 DL(%)=Total amount of drug added-Free amount of drugTotal weight of nanoparticles×100
All the experiments were performed in triplicate, results are presented as mean ± SD.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!